Quantbot Technologies’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,140
Closed -$89.3K 1753
2025
Q3
$89.3K Buy
+6,140
New +$87.5K ﹤0.01% 1448
2023
Q4
Sell
-5,942
Closed -$41.6K 1612
2023
Q3
$41.6K Sell
5,942
-15,600
-72% -$144K ﹤0.01% 1273
2023
Q2
$183K Buy
21,542
+7,042
+49% +$58.7K 0.01% 1000
2023
Q1
$133K Buy
+14,500
New +$185K 0.01% 1012
2022
Q4
Sell
-4,044
Closed -$68K 1715
2022
Q3
$68K Sell
4,044
-26,677
-87% -$573K 0.01% 1192
2022
Q2
$659K Buy
30,721
+22,278
+264% +$618K 0.06% 479
2022
Q1
$312K Buy
+8,443
New +$329K 0.03% 733
2021
Q4
Sell
-7,369
Closed -$466K 1544
2021
Q3
$466K Buy
+7,369
New +$561K 0.03% 625
2021
Q2
Sell
-5,601
Closed -$381K 1487
2021
Q1
$381K Buy
5,601
+5,551
+11,102% +$431K 0.04% 561
2020
Q4
$3K Buy
+50
New +$2.9K ﹤0.01% 1189
2019
Q4
Sell
-700
Closed -$15K 1251
2019
Q3
$15K Buy
700
+400
+133% +$11.1K ﹤0.01% 1135
2019
Q2
$10K Buy
+300
New +$9.6K ﹤0.01% 1087
2018
Q4
Sell
-2,776
Closed -$80K 1058
2018
Q3
$80K Sell
2,776
-407
-13% -$7.62K 0.01% 936
2018
Q2
$38K Buy
+3,183
New +$36.5K ﹤0.01% 1029

Other funds holding CDNA

Quantbot Technologies's CDNA Position: Q4 2025 in Review

Quantbot Technologies sold out of CareDx (CDNA) in Q4 2025, closing a stake of 6,140 shares — an estimated $89.3K sold.

Quantbot Technologies first reported a position in CDNA in Q2 2018 and held it in 14 quarters. The position peaked at $659K in Q2 2022. 200 funds tracked by Wall St. Rank hold CDNA as of Q4 2025.

  • Quantbot Technologies reported no remaining CareDx position as of Q4 2025 after selling out during the quarter.
  • Quantbot Technologies sold 6,140 CareDx shares in Q4 2025, an estimated $89.3K.
  • Quantbot Technologies first reported a position in CareDx in Q2 2018 and held it in 14 quarters.
  • Quantbot Technologies's CareDx position peaked at $659K in Q2 2022.
  • 200 funds tracked by Wall St. Rank held CareDx as of Q4 2025.

Based on Quantbot Technologies's 13F filing for Q4 2025, filed 10 Feb 2026.